Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Vibeke Strand
Keith A. Betts
Manish Mittal
Jinlin Song
Martha Skup
Avani Joshi
机构：
[1] Stanford University,
[2] Analysis Group,undefined
[3] Inc.,undefined
[4] AbbVie Inc.,undefined
来源：
Rheumatology and Therapy | 2017年 / 4卷
关键词：
Adalimumab; Matching-adjusted indirect comparison; Psoriatic arthritis; Secukinumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 362
页数：13
相关论文
共 50 条
  • [41] Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
    Garcia-Foncillas, J.
    Bokemeyer, C.
    Italiano, A.
    Keating, K.
    Paracha, N.
    Fellous, M.
    Marian, M.
    Fillbrunn, M.
    Gao, W.
    Ayyagari, R.
    Lassen, U. N.
    ANNALS OF ONCOLOGY, 2021, 32 : S401 - S401
  • [42] Comparative Effectiveness Without Head-to-Head Trials A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
    Signorovitch, James E.
    Wu, Eric Q.
    Yu, Andrew P.
    Gerrits, Charles M.
    Kantor, Evan
    Bao, Yanjun
    Gupta, Shiraz R.
    Mulani, Parvez M.
    PHARMACOECONOMICS, 2010, 28 (10) : 935 - 945
  • [43] Comparative Effectiveness of Secukinumab and Golimumab in Ankylosing Spondylitis: Assessed By Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data
    Maksymowych, Walter P.
    Choy, Ernest
    Yazici, Yusuf
    Walsh, Jessica A.
    Thom, Howard
    Kalyvas, Chrysostomos
    Fox, Todd
    Gandhi, Kunal
    Jugl, Steffen
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] COMPARATIVE EFFECTIVENESS IN PAIN AND HAQ-DI IMPROVEMENT FOR BARICITINIB VERSUS ADALIMUMAB, TOCILIZUMAB, AND TOFACITINIB MONOTHERAPIES IN CSDMARD-NAIVE RHEUMATOID ARTHRITIS PATIENTS: A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
    Fautrel, R.
    Zhu, B.
    Taylor, P. C.
    van de Laar, M.
    Emery, P.
    De Leonardis, F.
    Gaich, C.
    Nicolay, C.
    Kadziola, Z.
    De La Torre, I.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 973 - 974
  • [45] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Tahir, Hasan
    Maksymowych, Walter
    Choy, Ernest
    Yazici, Yusuf
    Walsh, Jessica
    Thom, Howard
    Kalyvas, Chrysostomos
    Fox, Todd
    Gandi, Kunal
    Jugl, Steffen
    RHEUMATOLOGY, 2018, 57
  • [46] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Maksymowych, W.
    Choy, E.
    Yazici, Y.
    Walsh, J.
    Thom, H.
    Kalyvas, C.
    Fox, T.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1301 - 1301
  • [47] Comparative Effectiveness in Pain and HAQ-DI Improvement for Baricitinib Versus Adalimumab, Tocilizumab, and Tofacitinib Monotherapies in Csdmard-Naive Rheumatoid Arthritis Patients: A Matching-Adjusted Indirect Comparison (MAIC)
    Fautrel, Bruno
    Zhu, Baojin
    Taylor, Peter C.
    van de Laar, Mart
    Emery, Paul
    de Leonardis, Francesco
    Gaich, Carol L.
    Nicolay, Claudia
    Kadziola, Zbigniew
    de la Torre, Inmaculada
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [48] A COST PER RESPONDER ANALYSIS OF SECUKINUMAB VS ADALIMUMAB BASED ON A MATCHING-ADJUSTED INDIRECT COMPARISON FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS FROM A GERMAN PAYER PERSPECTIVE
    Gunda, P.
    Kandhare, A.
    Nikoglou, E.
    Jugl, S. M.
    Kneidl, J.
    Neidhardt, K.
    VALUE IN HEALTH, 2016, 19 (07) : A537 - A537
  • [49] Comparative Effectiveness Without Head-to-Head TrialsA Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
    James E. Signorovitch
    Eric Q. Wu
    Andrew P. Yu
    Charles M. Gerrits
    Evan Kantor
    Yanjun Bao
    Shiraz R. Gupta
    Parvez M. Mulani
    PharmacoEconomics, 2010, 28 : 935 - 945
  • [50] Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
    Signorovitch, James E.
    Sikirica, Vanja
    Erder, M. Haim
    Xie, Jipan
    Lu, Mei
    Hodgkins, Paul S.
    Betts, Keith A.
    Wu, Eric Q.
    VALUE IN HEALTH, 2012, 15 (06) : 940 - 947
12345